Literature DB >> 21219956

Septic encephalopathy: inflammation in man and mouse.

Alexander Jacob1, James R Brorson, Jessy J Alexander.   

Abstract

Septic encephalopathy is a frequent complication of the sepsis syndrome, with no therapies available that can prevent the associated neurological dysfunction in humans. It is caused by a number of processes and networks going awry, the exact cellular and molecular mechanisms of which remain an enigma. Several mediators of inflammation have been assigned a key role in sepsis, including cytokines, chemokines and complement cascade. With the observations that brain dysfunction in a sepsis setting can be alleviated by regulation of the cytokines and complement proteins in various species of animals, optimism is building for a possible therapy of sepsis-damaged brain. This article reviewed the advances in the understanding of the underlying mechanisms causing pathology in SE, with an emphasis on the inflammatory and excitatory mediators such as the cytokines, complement proteins and neurotransmitters, investigating their potential as possible therapeutic targets.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21219956     DOI: 10.1016/j.neuint.2011.01.004

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  27 in total

Review 1.  Year in review 2010: Critical Care--Multiple organ dysfunction and sepsis.

Authors:  Etienne de Montmollin; Djillali Annane
Journal:  Crit Care       Date:  2011-12-05       Impact factor: 9.097

2.  Hospitalization, depression and dementia in community-dwelling older Americans: findings from the national health and aging trends study.

Authors:  Dimitry S Davydow; Kara Zivin; Kenneth M Langa
Journal:  Gen Hosp Psychiatry       Date:  2013-12-04       Impact factor: 3.238

Review 3.  Sepsis-Associated Encephalopathy: The Blood-Brain Barrier and the Sphingolipid Rheostat.

Authors:  Stephen J Kuperberg; Raj Wadgaonkar
Journal:  Front Immunol       Date:  2017-06-16       Impact factor: 7.561

4.  Preclinical models of overwhelming sepsis implicate the neural system that encodes contextual fear memory.

Authors:  Patricio T Huerta; Sergio Robbiati; Tomás Salvador Huerta; Anchal Sabharwal; Rose A Berlin; Maya Frankfurt; Bruce T Volpe
Journal:  Mol Med       Date:  2016-11-17       Impact factor: 6.354

5.  Phosphoinositide 3-kinase γ affects LPS-induced disturbance of blood-brain barrier via lipid kinase-independent control of cAMP in microglial cells.

Authors:  Adrian Frister; Caroline Schmidt; Nadine Schneble; Michael Brodhun; Falk A Gonnert; Michael Bauer; Emilio Hirsch; Jörg P Müller; Reinhard Wetzker; Reinhard Bauer
Journal:  Neuromolecular Med       Date:  2014-07-18       Impact factor: 3.843

Review 6.  Sepsis-associated encephalopathy.

Authors:  Teneille E Gofton; G Bryan Young
Journal:  Nat Rev Neurol       Date:  2012-09-18       Impact factor: 42.937

7.  In-hospital acute stress symptoms are associated with impairment in cognition 1 year after intensive care unit admission.

Authors:  Dimitry S Davydow; Douglas Zatzick; Catherine L Hough; Wayne J Katon
Journal:  Ann Am Thorac Soc       Date:  2013-10

8.  Assessing long-term neuroinflammatory responses to encephalopathy using MRI approaches in a rat endotoxemia model.

Authors:  Rheal A Towner; D Saunders; N Smith; W Towler; M Cruz; S Do; J E Maher; K Whitaker; M Lerner; K A Morton
Journal:  Geroscience       Date:  2018-02-07       Impact factor: 7.713

9.  Neurodegenerative evidence in mice brains with cecal ligation and puncture-induced sepsis: preventive effect of the free radical scavenger edaravone.

Authors:  Hiroki Yokoo; Seiichi Chiba; Kengo Tomita; Michinori Takashina; Hiroshi Sagara; Saburo Yagisita; Yasuo Takano; Yuichi Hattori
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

10.  Presepsis depressive symptoms are associated with incident cognitive impairment in survivors of severe sepsis: a prospective cohort study of older Americans.

Authors:  Dimitry S Davydow; Catherine L Hough; Kenneth M Langa; Theodore J Iwashyna
Journal:  J Am Geriatr Soc       Date:  2012-11-23       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.